Study Summary
This trial is being done to find out if the drug finerenone helps people with non-diabetic CKD.
- Chronic Kidney Disease
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: Up to approximately 50 months
Trial Safety
Safety Progress
Side Effects for
Trial Design
2 Treatment Groups
Finerenone (BAY94-8862)
1 of 2
Placebo
1 of 2
Experimental Treatment
Non-Treatment Group
1580 Total Participants · 2 Treatment Groups
Primary Treatment: Finerenone (BAY94-8862) · Has Placebo Group · Phase 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
North Carolina | 33.3% |
Texas | 33.3% |
Missouri | 33.3% |
How old are they?
18 - 65 | 50.0% |
65+ | 50.0% |
What site did they apply to?
St. Louis Heart & Vascular, PC | 100.0% |
What portion of applicants met pre-screening criteria?
Met criteria | 66.7% |
Did not meet criteria | 33.3% |
Frequently Asked Questions
To the best of your knowledge, is this research project without precedent?
"Finerenone (BAY94-8862), which was first studied in 2020, has had 2 clinical trials since then. The first one was sponsored by Bayer and occurred in 2020. After the initial Phase 3 drug approval 6000 people were enrolled. The second trial is currently ongoing and involves 448 cities across 39 countries." - Anonymous Online Contributor
For what standard medical condition is Finerenone (BAY94-8862) prescribed?
"Finerenone (BAY94-8862) is a medication with multiple uses. It is commonly used to treat cardiovascular mortality, but can also be given to patients suffering from heart failure, type 2 diabetes mellitus, and myocardial infarction." - Anonymous Online Contributor
Has Finerenone (BAY94-8862) received FDA sanctioning?
"Finerenone (BAY94-8862) has received a safety rating of 3. This is because Phase 3 trials, of which this medication is currently undergoing, have yielded some evidence of efficacy as well as multiple rounds data affirming its safety." - Anonymous Online Contributor
Are there other instances where Finerenone (BAY94-8862) has been tested in a controlled setting?
"There are currently two Phase 3 trials underway for Finerenone (BAY94-8862), with a total of 1205 study sites worldwide." - Anonymous Online Contributor